Patterson Health Center (PHC) is using Oracle Health CommunityWorks to drive efficiency across its clinical and financial operations to help improve patient care in rural Kansas communities. PHC is also adopting Oracle Health Clinical AI Agent, which will help alleviate administrative burdens for its clinicians and enable them to spend more time connecting with patients. As a result, PHC can expand access to healthcare in nearby underserved areas and better support patient care within its com

Ultrasound (US) imaging is a widely employed diagnostic tool used for real-time imaging of various organs and tissues using ultrasonic sound waves. The waves are sent into the body, and images are created based on how the waves reflect off internal tissues and organs. It is used for guiding many medical procedures, including biopsies and injections, and is important for dynamic monitoring of blood vessels. When the US is combined with photoacoustic (PA) imaging, where laser light pulses are u

Guardant Health, Inc, a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study to evaluate emerging multi-cancer detection (MCD) technology. Guardant’s Shield™ MCD test was selected for use in the four-year study, which aims to enroll up to 24,000 patients and evaluate the use of MCD tests—blood tests that can screen for several types of cancer simultaneously—in future randomiz

Remote robotic surgery offers the promise of world-class surgical care to patients in both underserved regions of developed countries and under-resourced countries. LivsMed is leading a revolution by fundamentally shifting the landscape, making advanced remote robotic surgery not only accessible, but also affordable for hospitals and patients worldwide with the introduction of STARK™, the company's first and the world's newest telesurgery-native robotic system. In part

InterSystems, a creative data technology provider managing over one billion healthcare records globally, and MyCLNQ Health, a digital health solutions leader, have announced a regional strategic partnership to help hospitals enhance patient engagement and increase service offerings across Asia. As part of the collaboration MyCLNQ will embed the InterSystems IRIS for Health™ data platform into its customizable, white-label mobile technologies to provide interoperability between MyCLNQ an

Waters Corporation and BD today announced a definitive agreement to combine BD's Biosciences & Diagnostic Solutions business with Waters, creating an innovative life science and diagnostics leader with pioneering technologies and an industry-leading financial outlook. The agreement is structured as a tax-efficient Reverse Morris Trust transaction valued at approximately $17.5 billion. Compelling Strategic and Financial Benefits The compan

IntelePeer, the leading end-to-end Conversational AI platform, today announced a strategic partnership with SOAP Health, the pioneer of AI-First Primary Care™, to transform both administrative and clinical efficiency across the healthcare industry. The collaboration combines IntelePeer’s SmartAgent™ and SmartAnalytics™ solutions with SOAP Health’s patented, animated, voice-based digital human ClinicalAI™ assistant to deliver a fully automated, smart patient

FUJIFILM Healthcare Americas Corporation, a leading provider of medical imaging and informatics solutions, today announced the launch of several advanced automated functions for its FDR Visionary Suite digital radiography room. Optimized to support high-volume imaging in hospital radiology departments and imaging centers, the automation features are designed to enhance workflow and improve the patient and technologist experience for a wide range of general radiology exams. The advan

Quest Diagnostics, a leader in diagnostic information services, including advanced diagnostics for brain health, today announced it plans to offer laboratory testing based on the Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma Ratio in-vitro diagnostic (IVD) test from Fujirebio, a global leader in the field of high-quality IVD testing. Quest plans to make the test available to physicians and biopharmaceutical collaborators later this summer. The test is the first blood-based IV

Exact Sciences Corp. a leading provider of cancer screening and diagnostic tests, today announced that its Oncodetect™ molecular residual disease (MRD) test has received Medicare coverage through the Centers for Medicare & Medicaid Services’ (CMS) Molecular Diagnostic Services Program (MolDX) for serial use in patients with stage II, III and resectable stage IV colorectal cancer (CRC) in the adjuvant and recurrence monitoring settings over a five-year period. The final LC